amarogentin has been researched along with Liver Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, W; Li, H; Wang, F; Wang, SW; Zhang, T; Zhang, Y; Zhao, H | 1 |
| He, Q; Li, H; Wang, F; Wang, S; Zhang, M; Zhang, T; Zhang, Y; Zhao, H | 1 |
2 other study(ies) available for amarogentin and Liver Cirrhosis
| Article | Year |
|---|---|
Protective Effects of Amarogentin against Carbon Tetrachloride-Induced Liver Fibrosis in Mice.
Topics: Actins; Albumins; Animals; Antioxidants; Carbon Tetrachloride; Cell Line; Dose-Response Relationship, Drug; Down-Regulation; Gentiana; Glycosides; Humans; Hydroxyproline; Iridoids; Liver Cirrhosis; Malondialdehyde; Mice; Mice, Inbred C57BL; Nucleotides, Cyclic; Oxidative Stress; Phytotherapy; Plant Extracts; Plant Roots; Swertia; Tissue Distribution | 2017 |
Serum metabonomics study of the hepatoprotective effect of amarogentin on CCl
Topics: Animals; Biomarkers; Carbon Tetrachloride; Discriminant Analysis; Disease Models, Animal; Drugs, Chinese Herbal; Gas Chromatography-Mass Spectrometry; Humans; Iridoids; Liver; Liver Cirrhosis; Male; Medicine, Chinese Traditional; Metabolic Networks and Pathways; Metabolome; Metabolomics; Mice; Mice, Inbred C57BL; Principal Component Analysis; Protective Agents; Tandem Mass Spectrometry | 2018 |